« Return to News | Study Conduct

BBK Worldwide expands with in-house distribution center

Tuesday, September 20, 2011 11:20 AM

In a joint effort with Ricoh Americas, BBK Worldwide has expanded its production facility to include full-service, in-house distribution services, called Distribution Central. "The motivation to provide these services through our sister creative company, Agency 320, is clear: reduce the time-to-market for critical materials that support the recruitment and retention of patients around the world," said Joan F. Bachenheimer, founding principal and CEO, BBK Worldwide.

"Communication materials languish on many desks during the long road to production and distribution to clinical research sites," continues Bachenheimer. BBK is committed to making the same robust tools currently available to study sites in the United States, available to study sites throughout the world. Distribution Central complements BBK's cultural adaptation, translation and variable in-house printing capabilities.

In addition to Distribution Central, BBK will be introducing the first-ever online document management system designed specifically to track recruitment and retention materials for clinical trials. BBK will be taking on full responsibility for regulatory submissions globally, and managing direct distribution to study sites on an expedited basis.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.